about
Nephrotoxic effects of common and emerging drugs of abuse.miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injuryUrinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.Accidental and iatrogenic causes of acute kidney injury.Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunctionGanciclovir-tenofovir interaction leading to tenofovir-induced nephrotoxicity.Drug-induced impairment of renal function.Supervised prediction of drug-induced nephrotoxicity based on interleukin-6 and -8 expression levels.Nephroprotective role of resveratrol and ursolic Acid in aristolochic Acid intoxicated zebrafish.DMSO-enhanced MALDI MS imaging with normalization against a deuterated standard for relative quantification of dasatinib in serial mouse pharmacology studies.Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Drug-drug interactions and acute kidney injury: caveat prescriptorPatient safety issues in CKD: core curriculum 2015.Polymyxin B Nephrotoxicity: From Organ to Cell Damage.Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.A Quantitative Approach to Screen for Nephrotoxic Compounds In VitroAssociations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study.Acute interstitial nephritis due to proton pump inhibitors.Evaluation of "Dream Herb," Calea zacatechichi, for Nephrotoxicity Using Human Kidney Proximal Tubule Cells.Kidney Toxicity Induced by 13 Weeks Exposure to the Fruiting Body of Paecilomyces sinclairii in Rats.Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study.Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based studyEffect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.Detection and management of nephrotoxicity during drug development.Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature.Risk factors for acute kidney injury in adult patients receiving vancomycin.Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.Drug absorption related nephrotoxicity assessment on an intestine-kidney chip.Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems.Extracellular nucleotides from dying cells act as molecular signals to promote wound repair in renal tubular injury.PCB77 Inducing Renal Tubular Cell Apoptosis.The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.THE PURVIEW OF PHYTOTHERAPY IN THE MANAGEMENT OF KIDNEY DISORDERS: A SYSTEMATIC REVIEW ON NIGERIA AND SOUTH AFRICA.Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.Acute kidney injury and disseminated intravascular coagulation due to mercuric chloride poisoning.Pemetrexed-Induced Nephrogenic Diabetes Insipidus.Role of heme oxygenase-1 in polymyxin B-induced nephrotoxicity in rats.
P2860
Q21558458-8E7347D4-797A-42EB-AD1A-D0BF099C5802Q28395772-BBAABFB4-1CB2-4383-ABA6-B8E48F0636F7Q33828918-4F673450-0C75-433E-B9FA-E79B965B93D5Q33954859-AB19770B-9C21-467E-8C76-38174AB07B04Q34172581-70E6C950-22BF-414C-84B1-3525F6315226Q34509133-AEDFB871-F440-460F-A0D2-5CADBA9B641DQ34731462-881FDCA3-CFC4-4AFD-B577-B384480D8930Q34913513-5A16B848-7921-4F6A-BEE2-96C5E25151EFQ35003653-B24D5B42-2F36-4AE3-9CEE-D7E61A8C00BEQ35016405-C4B51D0B-9714-41CE-A6D6-8AC431BB5EF5Q35154374-F9DBF23F-8F91-4158-B567-C16E45146178Q35155913-40011906-FDA5-4DFA-8FD3-3E425D93493EQ35339955-5C98BB41-4715-4CC8-9862-412465DC81D5Q35798287-D0FA85E5-9467-4F59-99CF-9032A4F45C45Q36105647-7E5C41CE-27CF-4BFA-B6E0-1C4ACA096EF2Q36106803-84562C16-2225-453A-B057-7DD163A4A1FBQ36173007-2F017B88-40A6-4E08-A27F-C7CA2D7978D4Q36746077-B98B4158-EC48-43C4-8200-3664B63416FEQ37078532-A3A3DD90-2EBB-412A-9B47-F44E9FC79499Q37091158-66FC6A3B-9672-4E3A-8877-852B16ECEBFDQ37293382-4C622C89-EF87-4209-A0B3-FDC4A58B884BQ37326412-8576382A-D949-4D9F-B4A7-FE18E6A56BA0Q37460471-267D14E3-B8E2-41F5-9E7D-689FE592AC75Q37533968-3D60B2EC-AC57-4084-B55C-F3FBF468F228Q37642208-4930B0BF-47C4-4796-8D95-465E16B68448Q38012203-B6A9591A-227B-49D6-88E0-19ABA3EF4541Q38105163-E1C340A4-F80E-43CE-840F-CE56B836F2C7Q38175357-241B0C3A-77D0-4408-8490-1206C0D8B7FCQ38287050-3D7249C7-0799-4A1C-9717-0EB5DB63DE47Q38707871-575467B1-AACA-4064-8777-51004607AC55Q38905001-DD48BBDF-E076-4CCA-A442-1CA6861B1C07Q38944042-B53937B4-2CC7-4F7D-86D5-452DD9693777Q38944955-85095601-9823-4B37-ACAC-2A3D274125EAQ39077216-572A86E6-7483-443A-A230-182FC041BA73Q39294722-12BC4141-71BC-4730-B6C4-9271C3995952Q39841690-3B875135-BB6F-4E29-B069-FC117EEB91C6Q40683631-9550B9D3-E64C-4858-A92C-C921E28F1786Q41270167-D5533970-C037-40DF-B360-3EDD7607DA4CQ41629910-3DE9E5CA-39BB-4AFF-861B-265E739FD6F8Q41882745-EB8010EC-72D3-4AA5-9F66-F810E2D6BA45
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Renal vulnerability to drug toxicity.
@en
Renal vulnerability to drug toxicity.
@nl
type
label
Renal vulnerability to drug toxicity.
@en
Renal vulnerability to drug toxicity.
@nl
prefLabel
Renal vulnerability to drug toxicity.
@en
Renal vulnerability to drug toxicity.
@nl
P356
P1476
Renal vulnerability to drug toxicity.
@en
P2093
Mark A Perazella
P304
P356
10.2215/CJN.02050309
P577
2009-06-11T00:00:00Z